Share
Nice report from A2M today and an earnings upgrade.
And, it’s all come from Synlait Infant Formula growth, all the other A2M markets are flat at best.
I’m also seeing an exceptional take up from Akarola infant formula sales also on the official Tmall site, Akarola is now selling at a greater rate than a2 platinum is on the A2M official Tmall site. Plus, the sign up of Walmart stores in China for Akarola could be enormous.
It all bodes really very well, and I think the market has totally under appreciated SML of late, perhaps even just because it’s not yet dual listed on the ASX.
It may well be hard to ignore HY reporting in five week's time though !
